Table 2 Results for p16 staining, Sanger sequencing and LCD-Array technique for squamous cell carcinomas, carcinoma in situ (Cais) and non-tumor tissue as well as overall
Sample | p16 | Sanger sequencing | LCD-Array technique | |||
|---|---|---|---|---|---|---|
positive (%) | negative (%) | positive (%) | negative (%) | positive (%) | negative (%) | |
Squamous cell carcinomas (n = 62) | 32/62 (52%) | 30/62 (48%) | 16/61 (26%) | 45/61 (74%) | 34/60 (57%) | 26/60 (43%) |
Cais (n = 6) | 4/6 (67%) | 2/6 (33%) | 1/6 (17%) | 5/6 (83%) | 6/6 (100%) | 0 (0%) |
non-tumor tissue (n = 69) | 3/68 (4%) | 65/68 (96%) | 4/68 (6%) | 64/68 (94%) | 18/66 (27%) | 48/66 (73%) |
Overall (n = 139) | 39/138 (28%) | 99/138 (72%) | 21/137 (15%) | 116/137 (85%) | 58/134 (43%) | 76/134 (57%) |